AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11372922 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 15
Study 9425975 — intervention group
Group type: EXPERIMENTAL
Intervention: L2 group (injection at the second lumbar vertebra)
Number of subjects: 30
Study 9425975 — intervention group
Group type: COMPARATOR
Intervention: L4 group (injection at the fourth lumbar vertebra)
Number of subjects: 30
Study 8276982 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg ibuprofen daily for 14 days in 4 divided doses
Number of subjects: 17
Study 8276982 — intervention group
Group type: COMPARATOR
Intervention: No drug regime (control group)
Number of subjects: 17
Study 3520384 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dihydroergotamine (DHE) and metoclopramide every 8 hours
Number of subjects: 109
Study 3520384 — intervention group
Group type: COMPARATOR
Intervention: Diazepam intravenously every 8 hours
Number of subjects: 109
Study 31879077 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplementation (20-g protein-rich supplement)
Number of subjects: 20
Study 31879077 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate supplementation (20-g calorie-matched carbohydrate-rich supplement)
Number of subjects: 20
Study 30700175 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRHa 0.1 mg subcutaneous injection on day 3 after embryo transfer (ET)
Number of subjects: 868
Study 30700175 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GnRHa)
Number of subjects: 868
Study 28100402 — intervention group
Group type: EXPERIMENTAL
Intervention: Late surfactant and inhaled nitric oxide
Number of subjects: 450
Study 28100402 — intervention group
Group type: COMPARATOR
Intervention: Inhaled nitric oxide alone (control)
Number of subjects: 450
Study 26337394 — intervention group
Group type: EXPERIMENTAL
Intervention: Day Camp Intervention Arm (DCIA)
Number of subjects: 115
Study 26337394 — intervention group
Group type: COMPARATOR
Intervention: Standard Intervention Arm (SIA)
Number of subjects: 115
Study 23382325 — intervention group
Group type: EXPERIMENTAL
Intervention: PulsePen
Number of subjects: 66
Study 23382325 — intervention group
Group type: EXPERIMENTAL
Intervention: A-Pulse
Number of subjects: 66
Study 23382325 — intervention group
Group type: COMPARATOR
Intervention: SphygmoCor
Number of subjects: 66
Study 23382325 — intervention group
Group type: COMPARATOR
Intervention: SphygmoCor and PulsePen
Number of subjects: 66
Study 22134568 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (up to 10 lesions per session, up to 4 sessions, every 3 months)
Number of subjects: 71
Study 22134568 — intervention group
Group type: COMPARATOR
Intervention: Imiquimod (3-times-per-week for 3-4 weeks, up to 2 courses)
Number of subjects: 71
Study 22134568 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 71
Study 22134568 — intervention group
Group type: COMPARATOR
Intervention: Imiquimod
Number of subjects: 71
Study 19461553 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet intervention
Number of subjects: 316
Study 19461553 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 316
Study 19461553 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and Diet intervention
Number of subjects: 316
Study 19461553 — intervention group
Group type: COMPARATOR
Intervention: Healthy Lifestyle Control group
Number of subjects: 316
Study 19461553 — intervention group
Group type: COMPARATOR
Intervention: Diet group
Number of subjects: 316
Study 19461553 — intervention group
Group type: COMPARATOR
Intervention: Exercise group
Number of subjects: 316
Study 18402286 — intervention group
Group type: EXPERIMENTAL
Intervention: Olprinone
Number of subjects: 30
Study 18402286 — intervention group
Group type: COMPARATOR
Intervention: Control (normal saline)
Number of subjects: 30
Study 15614026 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 97
Study 15614026 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 97
Study 15614026 — intervention group
Group type: COMPARATOR
Intervention: Irbesartan and Atenolol
Number of subjects: 97
Study 11724449 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-beta-1a (n=12)
Number of subjects: 26
Study 11724449 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=6)
Number of subjects: 26
Study 11724449 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically active MS patients
Number of subjects: 26
Study 11724449 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically stable MS patients
Number of subjects: 26
Study 11724449 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal study of active MS patients
Number of subjects: 26
Study 11724449 — intervention group
Group type: EXPERIMENTAL
Intervention: Active exacerbations in MS patients
Number of subjects: 26
Study 9219786 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole with norfloxacin
Number of subjects: 50
Study 9219786 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole with norfloxacin
Number of subjects: 50
Study 8432141 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled amiloride
Number of subjects: 9
Study 8432141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 2462444 — intervention group
Group type: EXPERIMENTAL
Intervention: Untreated Dacron aortic bifurcation graft
Number of subjects: 20
Study 2462444 — intervention group
Group type: COMPARATOR
Intervention: Gelatin impregnated Dacron aortic bifurcation graft
Number of subjects: 20
Study 29862617 — intervention group
Group type: EXPERIMENTAL
Intervention: Trelagliptin 100 mg with insulin (A/A group)
Number of subjects: 240
Study 29862617 — intervention group
Group type: COMPARATOR
Intervention: Placebo with insulin (P/A group)
Number of subjects: 240
Study 26887502 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage containing 55 mg BTP
Number of subjects: 0
Study 26887502 — intervention group
Group type: COMPARATOR
Intervention: Control beverage without BTP
Number of subjects: 0
Study 25590055 — intervention group
Group type: EXPERIMENTAL
Intervention: Human placental extract (HPE)
Number of subjects: 194
Study 25590055 — intervention group
Group type: COMPARATOR
Intervention: Control group (LE–FAD)
Number of subjects: 194
Study 25590055 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 194
Study 23241332 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance group (n = 15) - cognitive-motor exercise program with dance video gaming, 12 weeks, twice weekly.
Number of subjects: 31
Study 23241332 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 16) - strength and balance exercises only, 12 weeks, twice weekly.
Number of subjects: 31
Study 20375742 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballistic stretching
Number of subjects: 32
Study 20375742 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 32
Study 20375742 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 18515185 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal rotigotine 1 mg over 24 h (n=115)
Number of subjects: 458
Study 18515185 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal rotigotine 2 mg over 24 h (n=112)
Number of subjects: 458
Study 18515185 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal rotigotine 3 mg over 24 h (n=114)
Number of subjects: 458
Study 18515185 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=117)
Number of subjects: 458
Study 15696321 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (1.2 mg/kg) after 8 hours of abstinence
Number of subjects: 49
Study 15696321 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (1.2 mg/kg) after 4 hours of abstinence
Number of subjects: 49
Study 15696321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 11872051 — intervention group
Group type: EXPERIMENTAL
Intervention: Suturing of flaps with no drain
Number of subjects: 375
Study 11872051 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 375
Study 10534633 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% minoxidil
Number of subjects: 36
Study 10534633 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% minoxidil
Number of subjects: 36
Study 10534633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 10534633 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 36
Study 7485340 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg of aspirin daily
Number of subjects: 682
Study 7485340 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aspirin)
Number of subjects: 682
Study 2083805 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG with positive T wave in V1
Number of subjects: 64
Study 2083805 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-variable model (positive T wave in V1 + R/S ratio >= 1 in V1-V2)
Number of subjects: 64
Study 2083805 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-variable model (+ R wave duration in V1-V2 >= 0.04 sec)
Number of subjects: 64
Study 2083805 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D echocardiography with pertinent dyssynergy
Number of subjects: 64
Study 2083805 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard ECG
Number of subjects: 64
Study 2083805 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D echocardiography
Number of subjects: 64
Study 386118 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg three times a day) and dipyridamole (75 mg three times a day)
Number of subjects: 50
Study 386118 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin therapy (closely regulated)
Number of subjects: 50
Study 386118 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antiplatelet or anticoagulant therapy)
Number of subjects: 50
Study 30551792 — intervention group
Group type: EXPERIMENTAL
Intervention: ALGOS brief contact intervention (BCI)
Number of subjects: 987
Study 30551792 — intervention group
Group type: COMPARATOR
Intervention: Control group (no BCI)
Number of subjects: 987
Study 27402095 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic middle pancreatectomy (RA-MP)
Number of subjects: 100
Study 25536308 — intervention group
Group type: EXPERIMENTAL
Intervention: ABThera
Number of subjects: 45
Study 25536308 — intervention group
Group type: COMPARATOR
Intervention: Barker's vacuum pack
Number of subjects: 45
Study 24565455 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 889
Study 24565455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 889
Study 21471490 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-for-performance hospitals
Number of subjects: 260
Study 21471490 — intervention group
Group type: COMPARATOR
Intervention: Control hospitals
Number of subjects: 260
Study 21471490 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-for-performance hospitals with larger bonuses
Number of subjects: 260
Study 21471490 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-for-performance hospitals that were well financed
Number of subjects: 260
Study 21471490 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-for-performance hospitals in less competitive markets
Number of subjects: 260
Study 19448382 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (E)
Number of subjects: 57
Study 19448382 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-Vitamin (EV)
Number of subjects: 57
Study 19448382 — intervention group
Group type: COMPARATOR
Intervention: Vitamin (V)
Number of subjects: 57
Study 19448382 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 57
Study 17659736 — intervention group
Group type: EXPERIMENTAL
Intervention: Drain group
Number of subjects: 108
Study 17659736 — intervention group
Group type: COMPARATOR
Intervention: No-drain group
Number of subjects: 108
Study 14765044 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 0.10 microg kg(‐1) bolus 30 minutes before end of surgery
Number of subjects: 96
Study 14765044 — intervention group
Group type: COMPARATOR
Intervention: Tramadol 100 mg
Number of subjects: 96
Study 11211903 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (30 mg, administered orally once daily at 19:00 h for 14 days)
Number of subjects: 14
Study 11211903 — intervention group
Group type: COMPARATOR
Intervention: Placebo (administered orally once daily at 19:00 h for 14 days)
Number of subjects: 14
Study 9640149 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 40
Study 9640149 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40
Study 9640149 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental
Number of subjects: 40
Study 9640149 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 40
Study 9640149 — intervention group
Group type: COMPARATOR
Intervention: Halothane or Thiopental
Number of subjects: 40
Study 7927544 — intervention group
Group type: EXPERIMENTAL
Intervention: REmbIZ3 (rifampicin, ethambutol, isoniazid, pyrazinamide together in a single dose thrice weekly)
Number of subjects: 49
Study 7927544 — intervention group
Group type: EXPERIMENTAL
Intervention: REmb3IZ3alt (rifampicin, ethambutol on one day and isoniazid, pyrazinamide on the next day)
Number of subjects: 49
Study 2671282 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy and adjuvant doxorubicin and cyclophosphamide chemotherapy
Number of subjects: 88
Study 2671282 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiation therapy and chemotherapy
Number of subjects: 88
Study 2671282 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy alone
Number of subjects: 88
Study 793778 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg suloctidil t.i.d.
Number of subjects: 45
Study 793778 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg dihydroergotoxine methylate t.i.d.
Number of subjects: 45
Study 793778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 30919901 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary acid load (measured by net endogenous acid production, NEAP)
Number of subjects: 1045
Study 30919901 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of identified metabolites
Number of subjects: 1045
Study 29317269 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025-inch guidewire
Number of subjects: 710
Study 29317269 — intervention group
Group type: COMPARATOR
Intervention: 0.035-inch guidewire
Number of subjects: 710
Study 28475201 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-based balance training (4 weeks, twice a week) with real-time visual/audio feedback from wearable sensors.
Number of subjects: 22
Study 28475201 — intervention group
Group type: COMPARATOR
Intervention: Control group received no training.
Number of subjects: 22
Study 24590363 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype blood test for vCJD
Number of subjects: 5000
Study 22841358 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training for claudication
Number of subjects: 38
Study 19834348 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine-containing supplement (SUPP) - 400 mg caffeine, 66.7 mg capsicum extract, 10 mg bioperine, 40 mg niacin
Number of subjects: 21
Study 19834348 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC) - microcrystalline cellulose
Number of subjects: 21
Study 17647311 — intervention group
Group type: EXPERIMENTAL
Intervention: Radon baths and transcranial magnetotherapy
Number of subjects: 0
Study 16096896 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ampicillin (100 mg/kg/day divided every 6 h)
Number of subjects: 40
Study 16096896 — intervention group
Group type: COMPARATOR
Intervention: IV ampicillin plus IV gentamicin (5 mg/kg as a single daily dose)
Number of subjects: 40
Study 12807387 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/day
Number of subjects: 481
Study 12807387 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 400 mg/day
Number of subjects: 481
Study 12807387 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 600 mg/day
Number of subjects: 481
Study 12807387 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 800 mg/day
Number of subjects: 481
Study 12807387 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 481
Study 10713874 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimenhydrinate (1 mg kg‐1)
Number of subjects: 140
Study 10713874 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol (15 micrograms kg‐1)
Number of subjects: 140
Study 10713874 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of droperidol (15 micrograms kg‐1) + dimenhydrinate (1 mg kg‐1)
Number of subjects: 140
Study 10713874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 10713874 — intervention group
Group type: COMPARATOR
Intervention: All treatment groups compared to placebo
Number of subjects: 140
Study 7555612 — intervention group
Group type: EXPERIMENTAL
Intervention: L-lysine-L-arginine combination (lisargin)
Number of subjects: 0
Study 1932647 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (300 micrograms)
Number of subjects: 29
Study 1932647 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 29
Study 7335762 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen (200 mg b.i.d. by oral route)
Number of subjects: 16
Study 7335762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 6238923 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 8
Study 6238923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 30794364 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural regimen (NR) consisting of a cleanser with natural oils, beeswax, and witch hazel, and day and night creams with natural oils, glycerin, and botanical anti-inflammatories.
Number of subjects: 80
Study 30794364 — intervention group
Group type: COMPARATOR
Intervention: Synthetic regimen (CR) consisting of a cetyl alcohol, sodium lauryl sulphate-containing cleanser, and glycerin, polyisobutene-containing lotion.
Number of subjects: 80
Study 30794364 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural regimen (NR)
Number of subjects: 80
Study 30794364 — intervention group
Group type: COMPARATOR
Intervention: Synthetic regimen (CR)
Number of subjects: 80
Study 30794364 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens (NR and CR)
Number of subjects: 80
Study 29564752 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted low-intensity variant of the Triple P-Positive Parenting Program (Te Whānau Pou Toru)
Number of subjects: 70
Study 29564752 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 70
Study 26842716 — intervention group
Group type: EXPERIMENTAL
Intervention: PICC
Number of subjects: 80
Study 26842716 — intervention group
Group type: COMPARATOR
Intervention: CICVC
Number of subjects: 80
Study 25011730 — intervention group
Group type: EXPERIMENTAL
Intervention: computerised CBT (cCBT) using OCFighter, an internet-delivered OCD treatment package
Number of subjects: 0
Study 25011730 — intervention group
Group type: EXPERIMENTAL
Intervention: guided self-help (GSH) using a book
Number of subjects: 0
Study 22362228 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesoglycan (100 mg/day for 6 months)
Number of subjects: 68
Study 22362228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 20976505 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast injection speed (mean 0.38 ml/s)
Number of subjects: 56
Study 20976505 — intervention group
Group type: COMPARATOR
Intervention: Slow injection speed (0.05 ml/s over 40 s)
Number of subjects: 56
Study 20976505 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast injection speed
Number of subjects: 56
Study 20976505 — intervention group
Group type: COMPARATOR
Intervention: Slow injection speed
Number of subjects: 56
Study 16774821 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (S, 100 micro g/puff) administered via metered dose inhaler (MDI) with volume-controlled (VC) ventilation
Number of subjects: 10
Study 16774821 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (S, 100 micro g/puff) administered via metered dose inhaler (MDI) with pressure-support (PS) ventilation
Number of subjects: 10
Study 16774821 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 10
Study 16225925 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandage soft contact lens (BSCL) application
Number of subjects: 100
Study 12730756 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 35 mg once a week
Number of subjects: 485
Study 12730756 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily
Number of subjects: 485
Study 12730756 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily (Once-a-Week study)
Number of subjects: 485
Study 10407249 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed test for unobserved covariates
Number of subjects: 0
Study 10407249 — intervention group
Group type: COMPARATOR
Intervention: Logrank test
Number of subjects: 0
Study 8685751 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA), n = 19
Number of subjects: 57
Study 8685751 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy (OA), n = 18
Number of subjects: 57
Study 1833839 — intervention group
Group type: EXPERIMENTAL
Intervention: Dacron graft
Number of subjects: 25
Study 1833839 — intervention group
Group type: COMPARATOR
Intervention: PTFE graft
Number of subjects: 25
Study 6125288 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 8
Study 6125288 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol
Number of subjects: 8
Study 6125288 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol
Number of subjects: 8
Study 6125288 — intervention group
Group type: EXPERIMENTAL
Intervention: propranolol
Number of subjects: 8
Study 31533686 — intervention group
Group type: EXPERIMENTAL
Intervention: Walk this Way (WTW) intervention
Number of subjects: 40
Study 31533686 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 40
Study 28401352 — intervention group
Group type: EXPERIMENTAL
Intervention: Provisional-FKI
Number of subjects: 113